The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Stugeron 15 mg Tablets



JNTL Consumer Health I (Ireland) LimitedPA23490/024/001

Main Information

Trade NameStugeron 15 mg Tablets
Active SubstancesCinnarizine
Dosage FormTablet
Licence HolderJNTL Consumer Health I (Ireland) Limited
Licence NumberPA23490/024/001

Group Information

ATC CodeN07CA Antivertigo preparations
N07CA02 cinnarizine

Status

License statusAuthorised
Licence Issued19/04/1993
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceProduct not subject to prescription for pack sizes of up to 15 tablets, maximum dose 30 mg, maximum daily dose 60 mg.
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back